Antibiotics Market Size, Share, Development, Key Players and Opportunities by 2028

The Antibiotics are powerful medicines that are used to fight against bacterial infections and diseases. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. Antibiotics either kill the bacteria (bactericidal) or restrict it from reproducing and growing (bacteriostatic). The antibiotics market do not work against any viral infection.

Download PDF Copy: https://www.theinsightpartners.com/sample/TIPRE00003406

The Antibiotics Market was valued at US$ 44,111.31 million in 2020 and is projected to reach US$ 59,253.24 million in 2028; it is expected to grow at a CAGR of 4.0% during 2021–2028.

Antibiotics Market Segmentation:

By Drug Class

Sulfonamides
Aminoglycosides
Carbapenem
Macrolides
Fluoroquinolones
Penicillin
Cephalosporin

By Action Mechanism

Mycolic Acid Inhibitors
RNA Synthesis Inhibitors
DNA Synthesis Inhibitors
Protein Synthesis Inhibitors
Cell Wall Synthesis Inhibitors

Top Key Players:

Pfizer, Inc
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
Abbott,
GlaxoSmithKline Plc,
Sanofi,
Novartis AG,
Bayer AG,
Bristol Myers Squibb Company,
Eli Lilly and Company,
Astellas Pharma

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.